Digoxin therapy for heart failure: safe for women?
Rathore
Saif S
SS
Krumholz
Harlan M
HM
D000889:Anti-Arrhythmia Agents / Q000009:adverse effects / Q000592:standards / Q000627:therapeutic use*; D002316:Cardiotonic Agents / Q000009:adverse effects / Q000592:standards / Q000627:therapeutic use*; D004077:Digoxin / Q000009:adverse effects / Q000592:standards / Q000627:therapeutic use*; D005260:Female; D006329:Heart Conduction System / Q000187:drug effects / Q000473:pathology; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D008297:Male; D009656:North America; D018487:Ventricular Dysfunction, Left / Q000188:drug therapy; D016387:Women's Health
D000889:Anti-Arrhythmia Agents; D002316:Cardiotonic Agents; D004077:Digoxin